ARCHIVE SEARCH
      -OR-  
 
  NEWS CHANNELS
Fitness News
Asthma Allergy News
 > Diabetes News
Women's Health News
Men's Health News

  MY NEWS
Personal Archive
My Account

  ABOUT THIS NEWSFEED
About Us
Advertise With Us
Feed Your Site
Contact Us


Site Map
RSS News Feed 

  Website development & hosting
   by Cyber Software Solutions

 
Trulicity Approved for Type 2 Diabetes
New drug helps regulate blood sugar

FRIDAY, Sept. 19, 2014 (HealthDay News) -- Trulicity (dulaglutide) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes, which accounts for 90 percent of diabetes cases in the United States.

The drug contains a hormone that helps stabilize blood sugar at normal levels, the agency said in a news release. Trulicity's safety and effectiveness were evaluated in clinical trials involving 3,342 people with type 2 diabetes.

The drug has been studied as a standalone treatment and in combination with other therapies, the agency said.

Trulicity's label has a boxed warning that some lab rodents given the drug developed a certain type of thyroid tumor called medullary thyroid carcinoma (MTC). While it's not known if the drug could cause the same problem in people, those at risk of developing MTC shouldn't be given the drug, the FDA said.

The drug also should not be given to people with type 1 diabetes, those who have increased blood or urine ketones or to people with severe gastrointestinal problems, the agency warned.

The FDA said it is requiring additional studies of the drug to further evaluate its use in children, any cardiovascular risks and its potential to cause MTC.

Trulicity is produced by Eli Lilly, based in Indianapolis.

More information

To learn more about this approval, visit the FDA.



-- Scott Roberts

Copyright © 2014 HealthDay. All rights reserved.


Back to Top Stories
  GOOGLE ADS